CCL2 mitigates cyclic AMP‐suppressed Th2 immune response in human dendritic cells

Allergy ◽  
2020 ◽  
Vol 75 (8) ◽  
pp. 2108-2111
Author(s):  
Byoungjae Kim ◽  
Ji Woo Yeon ◽  
Ji Hyung Lee ◽  
Hyun‐Ji Lee ◽  
Junhyoung Byun ◽  
...  
2008 ◽  
Vol 38 (4) ◽  
pp. 1024-1032 ◽  
Author(s):  
Undine Lippert ◽  
Karolin Zachmann ◽  
David M. Ferrari ◽  
Herbert Schwarz ◽  
Edgar Brunner ◽  
...  

2011 ◽  
Vol 63 (5) ◽  
pp. 670-678 ◽  
Author(s):  
Ramses Ilarraza ◽  
Yingqi Wu ◽  
Francis Davoine ◽  
Cory Ebeling ◽  
Darryl J. Adamko

2016 ◽  
Vol 14 (1) ◽  
Author(s):  
Chiu-Ping Kuo ◽  
Kuo-Song Chang ◽  
Jue-Liang Hsu ◽  
I-Fang Tsai ◽  
Andrew Boyd Lin ◽  
...  

2003 ◽  
Vol 71 (9) ◽  
pp. 5254-5265 ◽  
Author(s):  
Isabelle Dimier-Poisson ◽  
Fleur Aline ◽  
Marie-Noëlle Mévélec ◽  
Céline Beauvillain ◽  
Dominique Buzoni-Gatel ◽  
...  

ABSTRACT Toxoplasma gondii, an obligate intracellular parasite pathogen which initially invades the intestinal epithelium before disseminating throughout the body, may cause severe sequelae in fetuses and life-threatening neuropathy in immunocompromised patients. Immune protection is usually thought to be performed through a systemic Th1 response; considering the route of parasite entry it is important to study and characterize the local mucosal immune response to T. gondii. Despite considerable effort, Toxoplasma-targeted vaccines have proven to be elusive using conventional strategies. We report the use of mesenteric lymph node dendritic cells (MLNDCs) pulsed ex vivo with T. gondii antigens (TAg) as a novel investigation approach to vaccination against T. gondii-driven pathogenic processes. Using a murine model, we demonstrate in two genetically distinct mouse strains (C57BL/6 and CBA/J) that adoptively transferred TAg-pulsed MLNDCs elicit a mucosal Toxoplasma-specific Th2-biased immune response in vivo and confer strong protection against infection. We also observe that MLNDCs mostly traffic to the intestine where they enhance resistance by reduction in the mortality and in the number of brain cysts. Thus, ex vivo TAg-pulsed MLNDCs represent a powerful tool for the study of protective immunity to T. gondii, delivered through its natural route of entry. These findings might impact the design of vaccine strategies against other invasive microorganisms known to be delivered through digestive tract.


2009 ◽  
Vol 11 (6-7) ◽  
pp. 661-670 ◽  
Author(s):  
Franck Skrzypek ◽  
Elio Cenci ◽  
Donatella Pietrella ◽  
Anna Rachini ◽  
Francesco Bistoni ◽  
...  

2017 ◽  
Vol 199 (15) ◽  
Author(s):  
J. Goret ◽  
L. Béven ◽  
B. Faustin ◽  
C. Contin-Bordes ◽  
C. Le Roy ◽  
...  

ABSTRACT Mycoplasma hominis lacks a cell wall, and lipoproteins anchored to the extracellular side of the plasma membrane are in direct contact with the host components. A Triton X-114 extract of M. hominis enriched with lipoproteins was shown to stimulate the production of interleukin-23 (IL-23) by human dendritic cells (hDCs). The inflammasome activation of the host cell has never been reported upon M. hominis infection. We studied here the interaction between M. hominis PG21 and hDCs by analyzing both the inflammation-inducing mycoplasmal lipoproteins and the inflammasome activation of the host cell. IL-23-inducing lipoproteins were determined using a sequential extraction strategy with two nondenaturing detergents, Sarkosyl and Triton X-114, followed by SDS-PAGE separation and mass spectrometry identification. The activation of the hDC inflammasome was assessed using PCR array and enzyme-linked immunosorbent assay (ELISA). We defined a list of 24 lipoproteins that could induce the secretion of IL-23 by hDCs, 5 with a molecular mass between 20 and 35 kDa and 19 with a molecular mass between 40 and 100 kDa. Among them, lipoprotein MHO_4720 was identified as potentially bioactive, and a synthetic lipopeptide corresponding to the N-terminal part of the lipoprotein was subsequently shown to induce IL-23 release by hDCs. Regarding the hDC innate immune response, inflammasome activation with caspase-dependent production of IL-1β was observed. After 24 h of coincubation of hDCs with M. hominis, downregulation of the NLRP3-encoding gene and of the adaptor PYCARD-encoding gene was noticed. Overall, this study provides insight into both protagonists of the interaction of M. hominis and hDCs. IMPORTANCE Mycoplasma hominis is a human urogenital pathogen involved in gynecologic and opportunistic infections. M. hominis lacks a cell wall, and its membrane contains many lipoproteins that are anchored to the extracellular side of the plasma membrane. In the present study, we focused on the interaction between M. hominis and human dendritic cells and examined both sides of the interaction, the mycoplasmal lipoproteins involved in the activation of the host cell and the immune response of the cell. On the mycoplasmal side, we showed for the first time that M. hominis lipoproteins with high molecular mass were potentially bioactive. On the cell side, we reported an activation of the inflammasome, which is involved in the innate immune response.


2008 ◽  
Vol 38 (6) ◽  
pp. 1767-1767
Author(s):  
Undine Lippert ◽  
Karolin Zachmann ◽  
David M. Ferrari ◽  
Herbert Schwarz ◽  
Edgar Brunner ◽  
...  

Author(s):  
VYu Talayev ◽  
MV Svetlova ◽  
IY Zaichenko ◽  
ON Babaykina ◽  
EV Voronina

Introduction: Vaccines are one of the most effective means of preventing infectious diseases. Their effectiveness and safety are guaranteed by studies of vaccine properties, during their development and during the mandatory preclinical and clinical trials of each new vaccine. Additional information on the mechanisms of vaccine action on human immune system cells can be obtained using in vitro immune response models. The objective of the study was to determine applicability of certain methods of studying human dendritic cells in vitro to assessing the effect of vaccines. Dendritic cells are the most active antigen presenting cells, which play a key role in triggering a primary immune response to an infection or vaccine. Materials and methods: We studied the effect of vaccines on the maturation of dendritic cells, their phagocytic activity and the ability to stimulate T-lymphocytes in vitro. Results: To test the methods, we used vaccines with a known pattern of action on the immune system. All the vaccines induced the expression of dendritic cell maturation markers. At the same time, different vaccines induced a different set of markers and the degree of expression of these molecules. Quantitative methods for assessing phagocytosis and stimulating activity of dendritic cells are described. Conclusion: Methods for evaluation of phagocytosis, phenotypic maturation and functional properties of dendritic cells have been shown to be useful for evaluation of vaccine action. In our opinion, these methods, as a complement to traditional methods for evaluating the immune response, can be used to investigate the action of prototype vaccines at the stage of their development and preclinical trials.


Sign in / Sign up

Export Citation Format

Share Document